News Hangzhou Alltest Biotech Co., Ltd.

Equities

688606

CNE1000053G6

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-23 pm EDT			5-day change	1st Jan Change
56.2 ^CNY	-0.34%		-2.18%	-18.08%

Apr. 29	China, HK stocks rise, led by property shares	RE
Apr. 26	Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China, HK stocks rise, led by property shares	Apr. 29	RE
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Tranche Update on Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback Plan announced on August 17, 2023.	Feb. 23	CI
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback announced on August 17, 2023, has closed with 1,030,000 shares, representing 1.32% for CNY 59.58 million.	Feb. 22	CI
Hangzhou Alltest Biotech Co., Ltd. agreed to acquire an unknown stake in Hangzhou Weisibo Medical Technology Co., Ltd.	Jan. 05	CI
Tranche Update on Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback Plan announced on August 17, 2023.	Jan. 02	CI
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Tranche Update on Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback Plan announced on August 17, 2023.	23-10-10	CI
Hangzhou Alltest Biotech Co., Ltd.(XSSC:688606) added to S&P Global BMI Index	23-09-18	CI
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Hangzhou Alltest Biotech Co., Ltd. announces an Equity Buyback for CNY 60 million worth of its shares.	23-08-16	CI
Hangzhou Alltest Biotech Co., Ltd. authorizes a Buyback Plan.	23-08-15	CI
Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback announced on July 22, 2022, has expired.	23-07-20	CI
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Hangzhou Tongzhou Biotechnology Co., Ltd. announced that it expects to receive CNY 19 million in funding from Hangzhou Alltest Biotech Co., Ltd.	23-01-08	CI
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Atomo Diagnostics Limited Signs Agreement with Hangzhou Alltest Biotech Co., Ltd, for Supply of A Covid-19 1 Rapid Antigen Self-Test in the Australian and New Zealand Markets	22-08-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hangzhou Alltest Biotech Co., Ltd.

Equities

688606

CNE1000053G6

Summary

Filters